XSES
NPL
Market cap17mUSD
May 02, Last price
0.18SGD
1D
0.00%
IPO
-14.63%
Name
Niks Professional Ltd
Chart & Performance
P/E
10.94
P/S
2.03
EPS
0.02
Div Yield, %
5.71%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
11m
+3.10%
Net income
2m
+23.31%
CFO
3m
+16.78%
Dividend
May 16, 20240.01 SGD/sh
Profile
Niks Professional Ltd is an integrated medical skin care provider, incorporating family dermatology and aesthetic medical services, skin care products, facial treatment and medical camouflage service under one roof and a single NIKS brand. It owns and operates three medical clinics in Singapore focusing on family dermatology and aesthetic medicine. its clinical services are complemented by a portfolio of some 200 quality medical skin care products. its products are conceptualized and developed in Singapore and made in the finest factories in the United States and Europe.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | 11,190 3.10% | 10,854 -2.17% | 11,095 -5.16% | ||
Cost of revenue | 1,814 | 8,150 | 7,602 | ||
Unusual Expense (Income) | |||||
NOPBT | 9,376 | 2,704 | 3,493 | ||
NOPBT Margin | 83.79% | 24.91% | 31.48% | ||
Operating Taxes | 407 | 488 | 406 | ||
Tax Rate | 4.34% | 18.05% | 11.62% | ||
NOPAT | 8,969 | 2,216 | 3,087 | ||
Net income | 2,079 23.31% | 1,686 -38.98% | 2,763 -17.25% | ||
Dividends | (1,300) | (9,500) | (3,660) | ||
Dividend yield | 46.84% | ||||
Proceeds from repurchase of equity | 4,578 | ||||
BB yield | -22.57% | ||||
| Debt | |||||
Debt current | 675 | 522 | 338 | ||
Long-term debt | 2,459 | 2,346 | 2,038 | ||
Deferred revenue | |||||
Other long-term liabilities | 80 | ||||
Net debt | (6,046) | (6,218) | (9,995) | ||
| Cash flow | |||||
Cash from operating activities | 2,561 | 2,193 | 3,387 | ||
CAPEX | (808) | (300) | (63) | ||
Cash from investing activities | (547) | (169) | (47) | ||
Cash from financing activities | (1,964) | (5,308) | (4,202) | ||
FCF | 8,535 | 869 | 3,475 | ||
| Balance | |||||
Cash | 9,180 | 9,086 | 12,371 | ||
Long term investments | |||||
Excess cash | 8,620 | 8,543 | 11,816 | ||
Stockholders' equity | 20,320 | 19,382 | 22,326 | ||
Invested Capital | 13,202 | 12,273 | 11,355 | ||
ROIC | 70.41% | 18.76% | 26.86% | ||
ROCE | 42.96% | 12.99% | 15.07% | ||
| EV | |||||
Common stock shares outstanding | 130,000 | 130,000 | 130,000 | ||
Price | 0.16 | ||||
Market cap | 20,280 | ||||
EV | 14,062 | ||||
EBITDA | 10,399 | 3,444 | 4,284 | ||
EV/EBITDA | 4.08 | ||||
Interest | 74 | 76 | 77 | ||
Interest/NOPBT | 0.79% | 2.81% | 2.20% | ||